Accounting for Biotech Equity: No Longer Easy for Big Pharma
Executive Summary
In the wake of several disastrous minority equity investments, drug companies are playing closer attention to where and how they account for minority equity when they put together partnerships. Accounting practices vary year-to-year and even case-by-case, but most drug companies are trying to neutralize expenses as soon as possible.